Sky Century Investment SKYI
OTC SKYI
$0.10 -0.03 (-23.08%)
At close: Aug 18, 2026 · 4:00 PM EDT

Sky Century Investment (SKYI) Enterprise Value (2012 - 2026)

Sky Century Investment (SKYI) posted quarterly Enterprise Value of -$264.0 for Q2 2026, up 97.67% year-over-year from -$133.56 in Q2 2025, and up 92.14% quarter-over-quarter from -$3360.0 in Q1 2026.

Sky Century Investment (SKYI) Enterprise Value (2012 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has reported Enterprise Value for 5 consecutive years, with -$264.0 the latest figure, recorded in Q2 2026.

  • In Q2 2026, Enterprise Value rose 97.67% year-over-year to -$264.0; the TTM figure through May 2026 stood at -$264.0 (up 97.67% YoY), while the FY2025 annual figure was -$477.0, changed N/A from the prior year.
  • Enterprise Value grew to -$264.0 in Q2 2026 per SKYI's latest filing, from -$3360.0 in the prior quarter.
  • Across five years, Enterprise Value topped out at -$264.0 in Q2 2026 and bottomed at -$11312.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -882.82 Mn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -3.65 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -1.68 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -5.79 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -2.66 Bn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -886.50 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -389.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -530.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -164.00 Mn
10 Sky Century Investment 393,547.71 393,283.71 26,045.00 -264.00

Historic Data

Download Data
DateValue
May 31, 2026 -264.00
Feb 28, 2026 -3,360.00
Nov 30, 2025 -467.00
Aug 31, 2025 -477.00
May 31, 2025 -11,312.00
Aug 31, 2014 -515.00
May 31, 2014 -515.00
Feb 28, 2014 -515.00
Nov 30, 2013 -5,565.00
Aug 31, 2013 -479.00
May 31, 2013 -154.00
Feb 28, 2013 -154.00
Nov 30, 2012 -354.00
Aug 31, 2012 -854.00